Indefinite Delivery Contract 36C24226D0075
- Not listed
- Veterans Integrated Service Network 2 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on August 24, 2026, with a ceiling of $240,583.99 for compounded chemotherapy drugs, in a single-award procurement with no set-aside designation. Place of performance is Chandler, Arizona. The contract stems from a sole-source solicitation (36C24226Q0550) issued April 20, 2026, to procure ready-to-administer, patient-specific chemotherapy drugs prepared under FDA 503A compliance, VHA...
- The Department of Veterans Affairs Veterans Integrated Service Network 10 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on May 1, 2026, for hazardous pharmaceutical compounding services, with a ceiling of $7,570,831.40 and an ultimate completion date of April 30, 2027. This is a single-award, no-set-aside contract. Optum Infusion Services 308, LLC will perform work at multiple VA Medical Centers across Indiana, Ohio, and Michigan, with administrative oversight at...
- Veterans Integrated Service Network 22 awarded a single-award indefinite-delivery contract to Optum Pharmacy 801, Inc. for $2,012,758.65 on October 1, 2024, to supply compounded chemotherapy medications. The contract has no set-aside designation and runs through September 30, 2026. Place of performance is Phoenix, Arizona. The originating solicitation sought supply and delivery of over 350 listed compounded chemotherapy products to the VA Long Beach Healthcare System, with a base period from...
- Optum Pharmacy 801, Inc., a 503A certified specialty pharmacy subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs for chemotherapy drug compounding services. The contract, valued at $124,987.94 with a period of performance through August 31, 2026, represents a firm fixed-price procurement with no set-aside designation. The awarded task order, issued September...
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, holds a single-award Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs Veterans Integrated Service Network 2 (VISN 2) for the provision of chemotherapy compound chemical mixes. The agreement, valued at $500,000, was awarded on August 24, 2021, with an ultimate completion date of August 23, 2026. The contract employs a firm fixed-price pricing structure with no set-aside designation,...
- This indefinite delivery contract was awarded by the Veterans Integrated Service Network 2, a civilian federal agency, to Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $1,071,930.52 and a period of performance from October 1, 2025 to September 30, 2026. The contract is for chemo compounding services, with a single task order for $1,071,930.52 to provide these services. The place of performance is Chandler, Arizona. No...
- Veterans Integrated Service Network 17 awarded a single-award indefinite-delivery contract to Optum Infusion Services 308, LLC for pharmacy compounding services focused on oncology drugs at the Dallas VA Healthcare System, with a contract ceiling of $6 million and an award date of November 1, 2025. The contract runs from November 1, 2025, through October 31, 2030. Performance occurs at the Dallas VA Medical Center (4500 S Lancaster Road, Dallas, Texas 75216) and the Garland VA Clinic, with...
- Veterans Integrated Service Network 17 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC, with a $500,000 ceiling on November 1, 2025, for Amarillo VA pharmacy compounding of oncology medications. This is a single-award contract without set-aside designation. Performance occurs at the Amarillo VA Healthcare System Pharmacy Services, 6010 W Amarillo Blvd, Amarillo, Texas 79106. The originating solicitation 36C25725Q0759, posted July 29, 2025, and due August 28, 2025,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a single-award indefinite-delivery contract to Optum Infusion Services 308, LLC on October 1, 2024, with a ceiling of $6,753,050 and performance through September 30, 2029. The contract covers pharmacy hazardous compounding services under Executive Order 14398. Work is performed at multiple locations including Biloxi, Mississippi and Pensacola, Florida, with operations supported from additional VA...
- This federal contract IDV award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 and Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award BPA, valued at up to $1,415,000, provides chemo compounding services to support the VA's oncology and infusion treatment programs when the agency's on-site compounding capabilities are temporarily unavailable. The contract tasks Optum...
- 36C24226D0075Indefinite Delivery Contract
- 1Federal Contract Awards
Veterans Integrated Service Network 2 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on September 1, 2026, with a ceiling value of $117,000.00 for chemotherapy compounding services at the Toms River VA facility through August 31, 2027. This is a single-award contract with no set-aside designation. Place of performance is Chandler, Arizona. The contract supports FDA 503A-compliant pharmaceutical compounding and hazardous chemotherapy preparation services, requiring next-day delivery capability and adherence to USP 797, 795, and 800 standards for aseptic compounding of hazardous and non-hazardous pharmaceutical agents and closed-system drug transfer devices. The estimated drug portfolio includes azacitidine, bortezomib, carboplatin, cisplatin, cyclophosphamide, irinotecan, oxaliplatin, carfilzomib, docetaxel, gemcitabine, pemetrexed, trastuzumab, fluorouracil, etoposide, doxorubicin, vincristine, mesna, and brentuximab, ranging from four to seventy units per drug. The underlying solicitation was issued as a sole-source award intent published June 11, 2026, with a response deadline of June 17, 2026. Prescriptions must be faxed by 11:30 AM the day before treatment and delivered by 8:00 AM on the treatment date. The contract is firm fixed price. A delivery order in the amount of $114,430.87 was issued under this IDIQ on September 1, 2026, also through August 31, 2027, for chemocompounding services at the Toms River VA facility.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 8/4/26 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C24226D0075-36C24226N0667 | Optum Infusion Services 308, LLC | $114.4k | 9/1/26 | 8/31/27 | 8/4/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--FY26QTR4 OPTUM HAZARDOUS DRUG COMPOUNDING, TOMS RIVER, NJ (VA-26-00071687) | 36C24226Q0705 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 | Special Notice 1/1 | 6/11/26, 6:22 PM |